Ophthalmology

New research highlights potential eye risks with semaglutide use

  There is a potential association between the use of semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA) commonly prescribed for type 2 diabetes and weight loss, and an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION), according to a study.   Researchers conducted a retrospective matched cohort...